Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Colombo

Showing results (41-50 of 372) with videos related to

Pageof 38
Sort By:
Gastroenterology|June 4, 2013
Selection of resistant-associated variants to the NS5A inhibitor daclatasvir: revenge of the hepatitis C virusAlessio Aghemo, Massimo Colombo
Clinics in Liver Disease|August 3, 2013
HBV infection and hepatocellular carcinomaMassimo Iavarone, Massimo Colombo
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 5, 2013
Practical insights into enhanced management of patients with HCV infection with direct antiviral agentsMassimo Colombo, Stephan Zeuzem
Gastroenterology|November 13, 2018
Is Liver Injury an Affordable Risk of Immune Checkpoint Inhibitor Therapy for Cancer?Massimo Colombo, Ana Lleo
Gastroenterology|February 26, 2014
Hepatitis C genotype 3: a tough match for interferon-free regimensAlessio Aghemo, Massimo Colombo
Gastroenterology|March 3, 2017
Response-Guided Duration of Direct Acting Antiviral Therapy for Chronic Hepatitis C: Back to the Future?Alessio Aghemo, Massimo Colombo
Gastroenterology|October 18, 2012
Insulin resistance and response to telaprevir plus pegylated interferon and ribavirin: a requiem for the HOMA score?Alessio Aghemo, Massimo Colombo
Gastroenterology|February 25, 2012
Proteomics to predict hepatitis C therapy outcome: where do we stand?Roberta D'Ambrosio, Massimo Colombo
Gastroenterology Clinics of North America|November 25, 2015
Extrahepatic Manifestations of Hepatitis C VirusMauro Viganò, Massimo Colombo
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 15, 2015
A therapeutic conundrum: Delaying ablation of small nonresectable early hepatocellular carcinoma to facilitate liver transplantationAngelo Sangiovanni, Massimo Colombo
Pageof 38

Showing results (41-50 of 372) with videos related to

Sort By:
Pageof 38
Gastroenterology|June 4, 2013
Selection of resistant-associated variants to the NS5A inhibitor daclatasvir: revenge of the hepatitis C virusAlessio Aghemo, Massimo Colombo
Clinics in Liver Disease|August 3, 2013
HBV infection and hepatocellular carcinomaMassimo Iavarone, Massimo Colombo
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 5, 2013
Practical insights into enhanced management of patients with HCV infection with direct antiviral agentsMassimo Colombo, Stephan Zeuzem
Gastroenterology|November 13, 2018
Is Liver Injury an Affordable Risk of Immune Checkpoint Inhibitor Therapy for Cancer?Massimo Colombo, Ana Lleo
Gastroenterology|February 26, 2014
Hepatitis C genotype 3: a tough match for interferon-free regimensAlessio Aghemo, Massimo Colombo
Gastroenterology|March 3, 2017
Response-Guided Duration of Direct Acting Antiviral Therapy for Chronic Hepatitis C: Back to the Future?Alessio Aghemo, Massimo Colombo
Gastroenterology|October 18, 2012
Insulin resistance and response to telaprevir plus pegylated interferon and ribavirin: a requiem for the HOMA score?Alessio Aghemo, Massimo Colombo
Gastroenterology|February 25, 2012
Proteomics to predict hepatitis C therapy outcome: where do we stand?Roberta D'Ambrosio, Massimo Colombo
Gastroenterology Clinics of North America|November 25, 2015
Extrahepatic Manifestations of Hepatitis C VirusMauro Viganò, Massimo Colombo
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 15, 2015
A therapeutic conundrum: Delaying ablation of small nonresectable early hepatocellular carcinoma to facilitate liver transplantationAngelo Sangiovanni, Massimo Colombo
Pageof 38